Everest joins race to manufacture Covid mRNA vaccines for China

Key topics to remember: By Richard Barbarossa China may not yet have a Covid-19 vaccine based on messenger RNA (mRNA) technology, which is generally considered even the most effective in preventing infections. But many are rushing to bring such vaccines into the country, even though the most recent official knowledge shows that a billion Chinese have already been vaccinated with various local vaccines based on older technologies. That crowd gained members last week when cancer and autoimmune disease drug startup Everest Medicines Ltd. (1952. HK) announced a distribution agreement in China for an mRNA jab developed through Canadian company Providence…